Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Posa

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 8, 2025
Lapdoctor: Multicentre Validation of a Scoring System for Preoperative Evaluation of Difficulty of Laparoscopic Donor NephrectomyJacopo Romagnoli, Gionata Spagnoletti, Francesco Emilio Rossini, et al.
Insights Into Imaging|November 8, 2024
Proceedings from an international consensus meeting on ablation in urogenital diseasesRoberto Iezzi, Andrea Contegiacomo, Alessandra De Filippis, et al.
European Radiology|September 2, 2018
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenibRoberto Iezzi, Maurizio Pompili, Emanuele Rinninella, et al.
European Journal of Radiology|April 22, 2019
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?Roberto Iezzi, Maurizio Pompili, Alessandro Posa, et al.
Life (Basel, Switzerland)|January 28, 2026
Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for SurgeryOr Schubert, Maria Chiara Sighinolfi, Filippo Gavi, et al.
Life (Basel, Switzerland)|June 26, 2026
Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. <i>Life</i> 2026, <i>16</i>, 73Or Schubert, Maria Chiara Sighinolfi, Filippo Gavi, et al.
Cancers|March 14, 2026
Retrospective Italian Registry on DSM-TACE: Experience Beyond Current RecommendationsPierleone Lucatelli, Maria Giulia Travaglini, Elio Damato, et al.
Cancers|January 8, 2023
Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional TreatmentsRoberto Iezzi, Afshin Gangi, Alessandro Posa, et al.
European Radiology|July 15, 2020
Impact of coronavirus disease 2019 (COVID-19) emergency on Italian radiologists: a national surveyDomenico Albano, Antonio Bruno, Federico Bruno, et al.
Transplantation Reviews (Orlando, Fla.)|July 8, 2021
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus ConferenceJacopo Romagnoli, Luca Tagliaferri, Anna Acampora, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 8, 2025
Lapdoctor: Multicentre Validation of a Scoring System for Preoperative Evaluation of Difficulty of Laparoscopic Donor NephrectomyJacopo Romagnoli, Gionata Spagnoletti, Francesco Emilio Rossini, et al.
Insights Into Imaging|November 8, 2024
Proceedings from an international consensus meeting on ablation in urogenital diseasesRoberto Iezzi, Andrea Contegiacomo, Alessandra De Filippis, et al.
European Radiology|September 2, 2018
TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenibRoberto Iezzi, Maurizio Pompili, Emanuele Rinninella, et al.
European Journal of Radiology|April 22, 2019
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?Roberto Iezzi, Maurizio Pompili, Alessandro Posa, et al.
Life (Basel, Switzerland)|January 28, 2026
Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for SurgeryOr Schubert, Maria Chiara Sighinolfi, Filippo Gavi, et al.
Life (Basel, Switzerland)|June 26, 2026
Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. <i>Life</i> 2026, <i>16</i>, 73Or Schubert, Maria Chiara Sighinolfi, Filippo Gavi, et al.
Cancers|March 14, 2026
Retrospective Italian Registry on DSM-TACE: Experience Beyond Current RecommendationsPierleone Lucatelli, Maria Giulia Travaglini, Elio Damato, et al.
Cancers|January 8, 2023
Emerging Indications for Interventional Oncology: Expert Discussion on New Locoregional TreatmentsRoberto Iezzi, Afshin Gangi, Alessandro Posa, et al.
European Radiology|July 15, 2020
Impact of coronavirus disease 2019 (COVID-19) emergency on Italian radiologists: a national surveyDomenico Albano, Antonio Bruno, Federico Bruno, et al.
Transplantation Reviews (Orlando, Fla.)|July 8, 2021
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus ConferenceJacopo Romagnoli, Luca Tagliaferri, Anna Acampora, et al.
Pageof 7